Who is sponsoring NCT05863975?

NCT05863975 is sponsored by Qianfoshan Hospital.

What condition does NCT05863975 study?

NCT05863975 studies HPV Infection.

What drugs are being tested in NCT05863975?

Interventions: Human interferon alpha 2b vaginal Effervescent capsules.

What is the status of NCT05863975?

NCT05863975 is currently UNKNOWN.

Last reviewed 2023-05-18 · How we verify

Treatment of HPV Infection in Perimenopausal and Postmenopausal Women

NCT05863975 PHASE4 UNKNOWN

A randomized controlled study was conducted to determine the effects of vaginal estrogen and human interferon alpha 2b vaginal effervescent capsules on vaginal microecology in perimenopausal and postmenopausal women. To determine whether there is a synergistic effect between the two in the treatment of HPV infection in perimenopausal and postmenopausal women. To observe the effects of two drugs alone and combined on the vaginal immune environment of patients.

Details

Lead sponsor	Qianfoshan Hospital
Phase	PHASE4
Status	UNKNOWN
Enrolment	150
Start date	Sat Jul 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Dec 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

HPV Infection

Interventions

Human interferon alpha 2b vaginal Effervescent capsules